Evercore ISI downgraded Exact Sciences (EXAS) to In Line from Outperform with an unchanged price target of $105.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences Approves Executive Bonus Acceleration Amid Abbott Merger
- Cathie Wood Doubles Down on This Bitcoin ETF, Cuts GitLab Stock (GTLB) Again
- Exact Sciences, Regeneron, Marvell, JFrog, Jazz: Trending by Analysts
- Exact Sciences downgraded to Hold from Buy at Stifel
- Private Markets: Prediction market platform Kalshi secures $300M